Hassan Urges Incoming Congress To Sustain U.S. Biomedical Strength
Schering-Plough CEO Fred Hassan is urging newly elected members of Congress to help preserve the strength of the U.S. biomedical industry in the face of rising foreign competition
You may also be interested in...
India is currently a viable option for simple chemistry outsourcing and offshoring; however, additional skill development is needed before medicinal chemistry and biology operations can be conducted there, speakers said at the Financial Times Global Pharmaceuticals & Biotechnology conference in London Sept. 18
Pending drug safety legislation from Sens. Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) may do more harm than good, FDA implied in comments submitted to the Senate Health Committee
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue